In a joint statement of National Cancer Institute-designated cancer centers, the UAB Comprehensive Cancer Center urges parents, young adults and physicians to increase HPV vaccination rates.
New UAB research demonstrates social factors that determine survival of younger patients with AML and present opportunities to improve outcomes.
The prostate-specific antigen, or PSA, test has limitations, but the new Prostate Health Index can offer an exact percentage of prostate cancer risk.
BCRFA continues to provide substantial gifts to UAB Cancer Center to accelerate breast cancer research.
Two highly acclaimed cancer researchers, Ravi Bhatia, M.D., and Smita Bhatia, M.D., MPH, will join UAB in January 2015.
In January, Ravi Bhatia, M.D., will take the helm as director of the Division of Hematology and Oncology and as deputy director of the UAB Comprehensive Cancer Center.
Pediatric cancer researcher Gregory Friedman, M.D., receives $40,000 grant to fight brain cancer in children.
Yang’s research focuses on a new class of drug – PARP inhibitors – that interfere with a cancer cell’s ability to repair DNA damage, hastening cell death.
The UAB community came out to support the CPS-3, becoming the largest single site enrollment in the U.S. with 1,209 participants.